Owner MOCHIDA PHARMACEUTICAL CO., LTD.

Inventors KAWANO, Hiroyuki; WATANABE, Hisayuki; NAKAMURA, Yusuke; SUGANO, Sumio; YANO, Takashi

Pub. Number AU-A-2002228418

PCT Pub. Number WO2002/061076

Priority 2001-25962 01.02.01 JP

Filing date 1 February 2002

Wipo publication date 12 August 2002

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12P 021/08 Preparation of peptides or proteins - Monoclonal antibodies

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 009/10 Drugs for disorders of the cardiovascular system